Medical device company, Anutra Medical, is now adding 1% lidocaine with epinephrine 1:100,000 to its product offerings, making this particular concentration of lidocaine more accessible to the dental market, according to a recent news release.
A published study that appeared in the Journal of Oral and Maxillofacial Surgery in October 2017, showed that buffered 1% lidocaine with epinephrine can be equally as effective as 2% lidocaine with epinephrine for a maxillary field block. This independent study by the University of North Carolina, Chapel Hill, found that buffering 1% lidocaine with epinephrine 1:100,000 with the Anutra Local Anesthetic Delivery System®, “reduces the pain on injection with a maxillary field block and results in similar lengths of pulpal anesthesia tested with a cold stimulus” as compared to the traditionally used 2% lidocaine with epinephrine 1:100,000.
As a result of the compelling study showing the benefits of the lower concentration of lidocaine, Anutra Medical is now adding 1% lidocaine with epinephrine, 1:100,000 as one of its regular product offerings.
In other studies conducted in April of 2017, utilizing the Anutra Local Anesthetic Delivery System, The School of Dentistry at the University of North Carolina, Chapel Hill, found that:
“Mean blood level differences of lidocaine for each patient were significantly lower after nerve block with the buffered drug compared with the non-buffered agent.”
The new product offerings will be available through all of Anutra Medical’s distribution partners, including Benco Dental.
Read studies on the science of buffering local anesthetics : https://anutramedical.com/sources/